European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP …Sacramento BeeTo address the remaining major objection, the CHMP required that CTI provide a literature review of mechanisms of rituximab resistance and analyses that…
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer TreatmentsForbesPrior to the FDA action, patients were required to get an infusion of rituximab the first day, followed by a pre-treatment diagnostic dose of radiolabeled indium-11…
Nature.comSuccess of immunomodulators in MS shifts discovery focus to neuroprotectionNature.comThe other Phase III candidates include Sanofi's oral dihydroorotate dehydrogenase inhibitor teriflunomide, Roche/Biogen Idec's injectable CD20-specif…
Novartis highlights advances for patients with breast cancer and hematological …Reuters (press release)Everolimus – Results from a Phase II study evaluating everolimus as a monotherapy in relapsed/refractory Hodgkin lymphoma (ASH abstract #2717; Dece…
Novartis Highlights Advances for Patients With Breast Cancer and Hematological …MarketWatch (press release)Everolimus – Results from a Phase II study evaluating everolimus as a monotherapy in relapsed/refractory Hodgkin lymphoma (ASH abstract #2717; …
National experts from the John Theurer Cancer Center will present 31 studies …PhysOrg.com (press release)269 – Randomized Phase II Trial Comparing GA101 (Obinutuzumab) with Rituximab in Patients with Relapsed CD20+ Indolent B-Cell Non Hodgkin Lymphom…
ifaonline.co.ukNICE gives green light to cancer drugHealth Insurance and Protection MagazineRituximab (marketed as MabThera by Roche) is a targeted therapy prescribed to people with follicular lymphoma, in combination with chemotherapy treatments. Evid…
Trial finds new drug combo increases remission time for lymphoma patientsecancermedicalscienceA trial led by French researchers has found that patients under 60 with a form of non-Hodgkin's lymphoma called 'diffuse large B-cell lymphoma' ar…
Fighting Cancer, Celebrating LifeHuffington PostChemo and a crazy protocol of a drug called Rituximab for two months this summer made me good as new. I thank the men and woman in white lab coats for that and on their behalf, I am writing you. "I t…
ecancermedicalscienceIntensive chemotherapy dramatically improves recurrence and survival in …ecancermedicalscienceYounger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive sign…